Chengdu huasun technology group Inc. , LTD. (SHE:000790)
China · Delayed Price · Currency is CNY 4.120
+0.040 (0.98%)
Apr 10, 2026, 12:19 PM CST
SHE:000790 Revenue
In the year 2025, Chengdu huasun technology group Inc. , LTD. had annual revenue of 545.50M CNY, down -36.86%. Chengdu huasun technology group Inc. , LTD. had revenue of 88.11M in the quarter ending December 31, 2025, a decrease of -56.14%.
Revenue
545.50M
Revenue Growth
-36.86%
P/S Ratio
4.67
Revenue / Employee
594.22K
Employees
918
Market Cap
2.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 545.50M | -318.48M | -36.86% |
| Dec 31, 2024 | 863.98M | -139.40M | -13.89% |
| Dec 31, 2023 | 1.00B | 130.27M | 14.92% |
| Jan 1, 2023 | 873.10M | -81.58M | -8.55% |
| Jan 1, 2022 | 954.69M | 195.38M | 25.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 886.96M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Anhui Huangshan Capsule | 460.42M |